Funded Tech Companies
Janpix
Wondering who provided funding to Janpix? GlaxoSmithKline, Johnson & Johnson Development Corporation and Medicxi Ventures joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Janpix
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1 Bdwy. 14th Floor
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Company Background Information
Overview
Janpix is discovering and developing inhibitors of Signal Transducer and Activator of Transcription proteins. Most members of this family of transcription factors have been known for some time and their relevance in certain cancers, in particular for STAT3 & STAT5, validated.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
10/13/2017
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Roman Fleck
Chief Scientific Officer
Patrick Gunning
VP - Bus. Development
Kay Noel
Company Investors
- GlaxoSmithKline
- Johnson & Johnson Development Corporation
- Medicxi Ventures (Giovanni Mariggi)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs